A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure

Shotaro Ito1, Hajime Asahina1, Naoko Yamaguchi2

  • 1Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.

Insights

SMARCA4-deficient thoracic undifferentiated carcinoma, a rare cancer linked to smoking, often presents as a mediastinal mass. This aggressive tumor can compress vital structures, and is typically resistant to radiation therapy.

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • SMARCA4-deficient thoracic sarcomatoid tumors are increasingly recognized as smoking-associated undifferentiated/dedifferentiated carcinomas, distinct from primary thoracic sarcomas.
  • These tumors are characterized by inactivating mutations in the SMARCA4 gene and predominantly affect middle-aged males with a history of smoking.

Observation:

  • A case study details a 39-year-old male with a mediastinal tumor causing respiratory and vascular compression, leading to severe right heart failure.
  • Initial palliative radiotherapy was ineffective, and the patient's condition rapidly declined, resulting in death within 7 weeks of hospitalization.

Findings:

  • Autopsy confirmed the diagnosis as SMARCA4-deficient thoracic undifferentiated carcinoma.
  • This tumor subtype demonstrates resistance to radiotherapy, highlighting the need for alternative treatment strategies.

Implications:

  • Early and accurate pathological diagnosis is crucial for managing SMARCA4-deficient thoracic undifferentiated carcinoma, especially in cases of mediastinal mass with vascular or airway compression.
  • Considering immune checkpoint inhibitors may be beneficial, as some cases have shown response to this therapy, warranting further investigation.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
187
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
144
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
146